Clinical trial

European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection

NCT06935487

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-04-01

PhaseNA

Study timeline

Study start (actual)2025-04-01Date precision: day

Registry last updated2025-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

transrectal ultrasound of prostate (TRUS) with AI software algorithmDIAGNOSTIC_TEST

MRI prostateDIAGNOSTIC_TEST

Sponsors & collaborators

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)lead sponsor

Angiogenesis Analyticscollaborator

Mapped research locations

BarcelonaSpain1 ParisFrance1 HamburgGermany1 MarseilleFrance1 AmsterdamNetherlands1 OsloNorway1 PadovaItaly1 BonnGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06935487 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.